Prognostic value of 18F‐FDG PET parameters in patients with locally advanced non‐small cell lung cancer treated with induction chemotherapy-Reference-Cited by-同舟云学术

Prognostic value of 18F‐FDG PET parameters in patients with locally advanced non‐small cell lung cancer treated with induction chemotherapy

Published:2019-11-28 Issue:1 Volume:16 Page:70-74
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia‐Pac J Clin Oncol

Author:

Lee Hee Yeon¹^ORCID,Choi Woo Hee²,Yoo Ie Ryung³,Park Jae Kil⁴,Sung Sook Whan⁴,Kim Yeon Sil⁵,Kang Jin‐Hyoung⁶^ORCID

Affiliation:

1. Department of Internal Medicine, Yeouido St. Mary's Hospital, College of MedicineThe Catholic University of Korea Seoul Republic of Korea

2. Departments of Radiology, St. Vincent's Hospital, College of MedicineThe Catholic University of Korea Seoul Republic of Korea

3. Department of Radiology, Seoul St. Mary's Hospital, College of MedicineThe Catholic University of Korea Seoul Republic of Korea

4. Department of Thoracic and Cardiovascular Surgery, Seoul St. Mary's Hospital, College of MedicineThe Catholic University of Korea Seoul Republic of Korea

5. Department of Radiation Oncology, Seoul St. Mary's Hospital, College of MedicineThe Catholic University of Korea Seoul Republic of Korea

6. Department of Internal Medicine, Seoul St. Mary's Hospital, College of MedicineThe Catholic University of Korea Seoul Republic of Korea

Publisher

Wiley

Subject

Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajco.13288

Reference14 articles.

1. Prognostic Relevance of Response Evaluation Using [18F]-2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography in Patients With Locally Advanced Non–Small-Cell Lung Cancer

2. Early Prediction of Response to First-Line Therapy Using Integrated 18F-FDG PET/CT for Patients with Advanced/Metastatic Non-small Cell Lung Cancer

3. Role of Positron Emission Tomography in the Early Prediction of Response to Chemotherapy in Patients With Non–Small-Cell Lung Cancer

4. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

5. Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pretreatment 18-FDG-PET/CT parameters can serve as prognostic imaging biomarkers in recurrent NSCLC patients treated with reirradiation-chemoimmunotherapy;Radiotherapy and Oncology;2023-08

2. Predictive value of 18F-FDG PET/CT for evaluating the response to hypofractionated radiotherapy combined with PD-1 blockade in non-small cell lung cancer;Frontiers in Immunology;2023-02-13

3. Clinical Significance of Expression of Periostin in Non-small Cell Lung Cancer;Journal of the College of Physicians and Surgeons Pakistan;2022-09-01

4. Ethnic Diversity of DPD Activity and the DPYD Gene: Review of the Literature;Pharmacogenomics and Personalized Medicine;2021-12